Medicina (Dec 2021)

Clinicopathological Characteristics and Survival Outcomes of Patients with Buccal Squamous Cell Carcinoma: Results of a Multi-Institutional Study

  • Shogo Shinohara,
  • Masahiro Kikuchi,
  • Hiroyuki Harada,
  • Kiyomi Hamaguchi,
  • Ryo Asato,
  • Hisanobu Tamaki,
  • Masanobu Mizuta,
  • Ryusuke Hori,
  • Tsuyoshi Kojima,
  • Keigo Honda,
  • Takashi Tsujimura,
  • Yohei Kumabe,
  • Kazuyuki Ichimaru,
  • Yoshiharu Kitani,
  • Koji Ushiro,
  • Koichi Omori

DOI
https://doi.org/10.3390/medicina57121361
Journal volume & issue
Vol. 57, no. 12
p. 1361

Abstract

Read online

Background and Objectives: To investigate clinicopathological characteristics and survival outcomes of patients with buccal cancer in Japan. Materials and Methods: This study was conducted using a database of 1055 patients with oral cancers treated between 2010 and 2017 at 12 institutions in Japan. Ninety-two patients (8.7%) with primary buccal cancer were extracted and clinicopathological characteristics and survival outcomes were compared between patients with buccal cancers and patients with other oral cancers. Results: Ages were significantly higher in the patients with buccal cancer (73 years old vs. 69 years old). Buccal cancer had less advanced cT stage and cN stage than other oral cancers. Overall 5-year survival (OS) was 80.6%, and recurrence-free 5-year survival (RFS) of buccal cancers was 67.8%, and there were no significant differences in survival compared with other oral cancers in terms OS or RFS (5y-OS: 82.5%, 5y-RFS: 74.4%). However, patients with stage IV buccal cancer showed poorer prognosis in terms of OS and RFS compared with the same stage patients with other oral cancer. Advanced T stage was the only factor independently associated with both OS and RFS of patients with buccal cancer in this study. Conclusions: Postoperative radiotherapy or chemoradiotherapy should be considered to improve survival outcome of buccal cancer patients, especially for the patients with advanced primary site disease or a higher cancer stage.

Keywords